Théodore Decaix

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Venous Thromboembolism

Atrial Fibrillation

Oral Anticoagulants

Top Venues

Aging clinical and experimental research

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Théodore Decaix, Kenza Kemache, Pierre Gay, Flora Ketz, Olivier Laprévote, Éric Pautas
Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants. Aging clinical and experimental research 36 (1) (2024)
Théodore Decaix, Kenza Kemache, Pierre Gay, Flora Ketz, Olivier Laprévote, Éric Pautas
Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants. Aging clinical and experimental research 36 (1) (2024)
Théodore Decaix, Kenza Kemache, Pierre Gay, Flora Ketz, Olivier Laprévote, Éric Pautas
Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants. Aging clinical and experimental research 36 (1) (2024)
Théodore Decaix, Sylvain Gautier, Luca Royer, Olivier Laprévote, Thomas Tritz, Virginie Siguret, Laurent Teillet, Cyril Sellier, Marion Pépin
Importance of cytochrome 3A4 and 2D6-mediated drug-drug interactions in oxycodone consumption among older adults hospitalized for hip fracture: a cross-sectional study. Aging clinical and experimental research (2023)
Théodore Decaix, Romain Magny, Isabelle Gouin-Thibaut, Xavier Delavenne, Patrick Mismetti, Joe-Elie Salem, Céline Narjoz, Anne Blanchard, Marion Pépin, Nicolas Auzeil, Marie-Anne Loriot, Olivier Laprévote
Plasma lipidomic analysis to investigate putative biomarkers of P-glycoprotein activity in healthy volunteers. Clinical and translational science (2023)
Théodore Decaix, Kenza Kemache, Pierre Gay, Olivier Laprévote, Flora Ketz, Éric Pautas
Correction to: Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation: a cross‑sectional study. Drugs & aging (2023)
Théodore Decaix, Kenza Kemmache, Pierre Gay, Olivier Laprévote, Flora Ketz, Éric Pautas
Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation: a cross-sectional study. Drugs & aging (2023)